JAMA Study Continues Wave Of Accelerated Approval Criticism Amid Expansion Of Pathway

Sponsors are increasingly using the accelerated approval pathway, but research continues to be critical about its aspects.

Box fighters trainning outdoor . Mixed media

Drugmakers have increasingly been pursuing the accelerated approval route after 2010, but the regulatory pathway has nonetheless been subject to a fresh wave of criticism from researchers, with the Journal of the American Medical Association (JAMA) most recently raising concerns.

In an Aug. 15 article, the London School of Economics and Political Science's Huseyin Naci and Katelyn Smalley and Harvard...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from Pathways & Standards